---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-22-011747"
form_type: "8-K"
ticker: "RCUS"
cik: "0001724521"
company_name: "Arcus Biosciences, Inc."
filed_at: "2022-06-16T23:59:59+00:00"
generated_at: "2026-06-25T01:19:52.706217+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Arcus Biosciences revises non-employee director compensation, effective June 14, 2022

## Summary
- Annual cash retainer set at $45,000 per director; additional retainers for lead independent director ($5,000) and committee chairs/members.
- Initial equity award with ~$625,000 grant date fair value, split 2/3 stock options and 1/3 RSUs, vesting over 3 years.
- Annual equity award with ~$350,000 grant date fair value, same option/RSU split, vesting fully after 12 months or next annual meeting.
- All equity vests fully upon a change in control; new directors do not receive an annual award in the same calendar year.

## SEC filing metadata
- accession: 0000950170-22-011747
- form_type: 8-K
- ticker: RCUS
- cik: 0001724521
- company_name: Arcus Biosciences, Inc.
- filed_at: 2022-06-16T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.07, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1724521/000095017022011747/0000950170-22-011747-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1724521/000095017022011747/rcus-20220614.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-22-011747
- JSON: https://secwatch.observer/filing/0000950170-22-011747.json
- Plain text: https://secwatch.observer/filing/0000950170-22-011747.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.